Drug Profile
Research programme: Type 2 diabetes mellitus implant - Titan Pharmaceuticals
Latest Information Update: 28 Dec 2021
Price :
$50
*
At a glance
- Originator Titan Pharmaceuticals
- Class Peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 28 Dec 2021 No recent reports of development identified for research development in Type-2-diabetes-mellitus in USA
- 09 Nov 2017 Early research in Type-2 diabetes mellitus in USA (unspecified route)